GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (ASX:EPN) » Definitions » Selling and Marketing Expense

Epsilon Healthcare (ASX:EPN) Selling and Marketing Expense : A$0.31 Mil (TTM As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Epsilon Healthcare Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Epsilon Healthcare's Selling and Marketing Expense for the six months ended in Jun. 2023 was A$0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.31 Mil.

Epsilon Healthcare Selling and Marketing Expense Historical Data

The historical data trend for Epsilon Healthcare's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epsilon Healthcare Selling and Marketing Expense Chart

Epsilon Healthcare Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Selling and Marketing Expense
Get a 7-Day Free Trial 0.40 0.67 0.83 0.42 0.34

Epsilon Healthcare Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.36 0.04 0.31 -

Epsilon Healthcare Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epsilon Healthcare Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Epsilon Healthcare's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Epsilon Healthcare (ASX:EPN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Epsilon Healthcare Ltd (ASX:EPN) » Definitions » Selling and Marketing Expense
Comparable Companies
ASX:BOD ASX:ME1 ASX:HGV ASX:MXC ASX:EXL ASX:BP8 ASX:AGH ASX:IDT ASX:PXS ASX:ECS ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
HDRPF:USA
Address
35 Lime Street, Suite 305, Level 3, Sydney, NSW, AUS, 2000
Website
https://www.epsilonhealthcare.com.au
Epsilon Healthcare Ltd is a diversified global healthcare and pharmaceuticals company. It owns number of medicinal cannabis assets including the cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic, and the Medimar Platform an end to end ecommerce solution for nutraceuticals and cannabis. EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.

Epsilon Healthcare (ASX:EPN) Headlines

No Headlines